|
HS Code |
142710 |
| Chemicalname | 5-Bromo-2-(1H-tetrazol-5-yl)pyridine |
| Casnumber | 861911-88-6 |
| Molecularformula | C6H4BrN5 |
| Molecularweight | 226.04 g/mol |
| Appearance | Off-white to light yellow powder |
| Purity | Typically ≥98% |
| Solubility | Soluble in DMSO, Dimethylformamide |
| Smiles | C1=CN=C(C=C1Br)C2=NNN=N2 |
| Inchi | InChI=1S/C6H4BrN5/c7-5-1-2-8-6(3-5)4-9-11-12-10-4/h1-3H,(H,9,10,11,12) |
| Storage | Store at 2-8°C, protected from light |
| Synonyms | 5-Bromo-2-pyridyl-tetrazole |
| Hazardclass | Irritant |
As an accredited 5-Bromo-2-(1H-tetrazol-5-yl)pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 5 grams of 5-Bromo-2-(1H-tetrazol-5-yl)pyridine, labeled with hazard warnings and product details. |
| Container Loading (20′ FCL) | 20′ FCL container loading for 5-Bromo-2-(1H-tetrazol-5-yl)pyridine involves secure, moisture-proof packaging to ensure safe chemical transport. |
| Shipping | 5-Bromo-2-(1H-tetrazol-5-yl)pyridine is shipped in tightly sealed containers, protected from moisture and light. Packaging complies with chemical safety standards, suitable for laboratory reagents. Transport is conducted by certified carriers, with labeling in accordance with applicable regulations for hazardous materials to ensure safe and compliant delivery to the destination. |
| Storage | Store **5-Bromo-2-(1H-tetrazol-5-yl)pyridine** in a tightly closed container, in a cool, dry, and well-ventilated area. Protect from light, moisture, heat, and incompatible substances such as strong oxidizers. Keep away from sources of ignition and direct sunlight. Ensure proper labeling and secure storage to prevent unauthorized access. Use appropriate personal protective equipment when handling the chemical. |
| Shelf Life | 5-Bromo-2-(1H-tetrazol-5-yl)pyridine should be stored tightly sealed; shelf life is typically 2–3 years under cool, dry conditions. |
|
Purity 98%: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine with purity 98% is used in pharmaceutical intermediate synthesis, where high purity ensures minimal by-product formation. Melting point 185°C: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine with melting point 185°C is used in medicinal chemistry research, where consistent thermal properties support reproducible outcomes. Particle size ≤10 µm: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine of particle size ≤10 µm is used in heterocyclic compound formulation, where fine particle distribution enhances reaction rates. Stability up to 110°C: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine with stability up to 110°C is used in catalyst development, where thermal stability enables robust process conditions. Moisture content <0.5%: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine with moisture content <0.5% is used in analytical standard preparation, where low moisture prevents sample degradation. HPLC assay >99%: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine with HPLC assay >99% is used in active pharmaceutical ingredient manufacture, where high assay guarantees batch consistency. LogP value 1.2: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine with LogP value 1.2 is used in lead optimization screens, where optimal solubility improves biological activity assessment. Residual solvent <0.05%: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine with residual solvent <0.05% is used in high-purity chemical libraries, where low solvent content supports analytical precision. Storage under inert gas: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine stored under inert gas is used in moisture-sensitive synthesis routes, where controlled storage preserves chemical integrity. Spectral purity NMR >99%: 5-Bromo-2-(1H-tetrazol-5-yl)pyridine with spectral purity NMR >99% is used in structure-activity relationship studies, where pure spectra ensure accurate molecular profiling. |
Competitive 5-Bromo-2-(1H-tetrazol-5-yl)pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Living in the world of organic chemistry, I’ve noticed that some molecules punch above their weight — quietly, without the fanfare of buzzwords. 5-Bromo-2-(1H-tetrazol-5-yl)pyridine fits this category. Behind the technical name hides an understated tool for synthesis that’s caught the attention of folks working in drug discovery, fine chemical research, and custom material development. The past decade saw an uptick in heterocycle-based innovation, yet reliable starting materials keep slip-sliding between supply gaps and inconsistent purity, often leading to wasted time and confusing results.
This compound carries a pyridine ring attached to a bromo substituent and a tetrazole group, which opens doors for a range of chemical modifications. Chemists seeking to introduce nitrogen-dense fragments in their libraries recognize the value of the tetrazole: it mimics carboxylic acids, improves hydrogen bonding, and brings metabolic stability that aromatic rings alone can’t offer. In pharmaceutical contexts, that extra tetrazole nitrogen network sometimes replaces entire fragments in lead compounds to overcome bioavailability issues or dodge patent thickets.
Every synthetic project I’ve worked on demanded compounds that behave predictably. For research that branches out in new directions—including fragment-based drug design or late-stage diversification—reagent dependability makes or breaks progress. Products labeled with shorthand like "Model 1123" don’t mean much outside catalogues, but material identity and reproducibility matter more than any branding. In this case, 5-Bromo-2-(1H-tetrazol-5-yl)pyridine doesn’t try to cloak itself in confusion. Labs report routine availability as a well-defined white to off-white powder, with spectral data and purity levels above ninety-five percent by HPLC. That’s a comfort built on solid supporting evidence, not just marketing copy.
Comparing options for introducing both a halide handle and a tetrazole, I’ve seen some bottlenecks with alternative compounds. For instance, 5-bromopyridine works as a halogenated precursor, but it leaves a gap in nitrogen-rich substitution. 5-Bromo-2-carboxypyridine shows up more often, but carboxylic acid chemistry sometimes limits functional group compatibility. If your synthetic path demands more latitude, tetrazoles outperform carboxylic acids for bioisosteric purposes, offering robust reaction windows under both acidic and basic conditions. They hang tough in peptide conjugation and withstand conditions that would destroy some conventional precursors.
That flexibility translates into real benefits for researchers who need to pivot quickly between approaches. I’ve watched colleagues switch from an acid to a tetrazole substituent mid-project simply to avoid a stubborn protecting group step, or to skirt patent claims. Instead of retooling the whole synthesis, incorporating 5-Bromo-2-(1H-tetrazol-5-yl)pyridine allowed for modular chemistry—especially useful for click reactions, cross-coupling, or cycloadditions. It removes a layer of hassle, which means fewer late nights in the lab staring at unreliable TLC plates.
Many compounds marketed as “building blocks” don’t always hold up under scrutiny. Even minor inconsistencies in purity—sometimes just a few percent off—can derail complex synthesis or confound biological testing. A smooth pathway from raw material to finished molecule depends on that supply chain, and too many times, I’ve heard the same story: commercial suppliers cut corners, skip full spectral characterization, or relabel repackaged lots. When a compound like this one maintains transparency about its preparation, spectral signatures, and impurity profiles, it builds the kind of trust that can’t be replicated with glossy datasheets.
The current scientific landscape doesn’t forgive short-term fixes. Lab budgets might fluctuate, but wasted effort stings much more. I’ve spent enough time chasing mystery peaks in LC/MS just to finally track them back to a slipshod batch of a crucial heterocycle. Now, I ask for independently verified NMR and HPLC reports, not just boilerplate promises. Reliable lots of 5-Bromo-2-(1H-tetrazol-5-yl)pyridine stand out in that regard, as working chemists quickly notice when a batch consistently dissolves, chromatographs, and reacts just as described. Suspicion drops when the evidence matches up, freeing up energy for real problem-solving, not debugging unexpected byproducts.
Some compounds loom large only in one field, but this one finds broader purpose. My own experience started in small-molecule medicinal chemistry, but I've since run across industry use in agrochemical research and material science. By offering a bromo leaving group on a pyridine core, the molecule invites both Suzuki and Buchwald-Hartwig cross-coupling. This means easy installation of aryl, alkyl, and heteroaryl groups, taking the product far beyond just drug building. The tetrazole ring increases water solubility compared to many pyridine compounds, which proves a boon in formulation chemistry, where dissolving stubborn intermediates is sometimes half the battle.
For researchers exploring metal complex catalysts or advanced material interfaces, access to nitrogen-rich ligands like this one enables tuning of electronic properties. In one project, colleagues used it to tether metal ions for catalytic studies, taking advantage of both the orientational control of the pyridine and the coordinating ability of the tetrazole. Small changes in the starting block ripple outward throughout a research program. When a molecule delivers both tunability and reliable function, it shoulders unforeseen challenges without fuss.
Every synthetic chemist remembers stalled reactions and product decompositions that trigger troubleshooting marathons. One lesson learned the hard way: some commercially available heterocycles accumulate trace metals, raising havoc with catalysis. Too many tools act inert in some hands, but unpredictable in others, all due to dodgy purification methods. I’ve trusted 5-Bromo-2-(1H-tetrazol-5-yl)pyridine lots only after confirming clean elemental analysis and checking for heavy metal contamination. Workups and purification steps feel less like a coin toss, more like a tested routine.
On another front, safety data for related compounds often drifts into uncertainty. Run-of-the-mill bromo-pyridines deliver the expected warnings, but the tetrazole group’s reputation as an energetic fragment can cause nervousness in some environments. Still, in practical handling under typical lab safety conditions—gloves, eye protection, fume hood—I haven’t encountered incidents or regulatory snags, provided the stock came from a verified batch with a real chemical pedigree. It boils down to transparency and documentation, not just hazard phrasing.
Academic labs frequently cut corners by sourcing the cheapest building blocks, but reliability trumps rock-bottom pricing over a project’s full scope. For a colleague’s work on kinase inhibitor analogues, inconsistent supply of the bromo-tetrazole subunit sent dozens of analogues to the trash bin. Finicky behavior under microwave conditions, unexpected color changes, and shifting TLC profiles all pointed to upstream variability—not shoddy chemistry, but a risky source.
After standardizing on a high-quality, audited supplier of this compound, the project pace picked up. Cross-coupling yields grew tighter, and the team logged fewer failures due to starting material quirks. That saved time, but more importantly, it improved confidence—both in data reproducibility and in telling a truthful scientific story. Nothing shreds the credibility of a publication or patent faster than a hidden impurity or batch-specific artifact. In my book, a dollar saved on starting material doesn’t offset wasted months of clean-up work.
Both university teams and industrial chemists wage an ongoing battle against supply chain unpredictability. Industry likes to believe it enjoys superior access to certified material, while academic labs hunt bargain bins. In reality, everyone pays for weak links along the way. The bromo-tetrazole ring system in this compound helps bridge workflows between discovery, optimization, and process scale-up. Its modularity lets exploratory teams pivot alongside ever-changing project goals. Genuine transparency around physicochemical data, storage stability, and impurity thresholds breaks down barriers between what’s advertised and what’s delivered.
With growing regulatory pressures on impurity profiles, especially in pharmaceutical intermediates, more eyes scrutinize every synthetic step. Having a robustly documented source for your halogenated heterocycles gives both the process team and the compliance folks less to argue about. Any hiccup in your source material—say, just a half-percent unknown by HPLC—can torpedo a scale-up run and trigger costly investigations. I’ve seen that cycle repeat on projects lacking rigor in their building block selection. A track record of reliable 5-Bromo-2-(1H-tetrazol-5-yl)pyridine batches allows chemists to move downstream with fewer regulatory headaches and less revalidation.
Green chemistry matters more with every passing year, not as a marketing checkbox but as an outcome we all feel in tighter regulations and steeper waste disposal costs. This molecule brings opportunities for efficient reactions: predictable leaving group reactivity means milder conditions, less energy use, and cleaner purifications. Peers in my network have noted that the tetrazole-pyridine core serves as a versatile hub for “click” chemistry, simplifying both reaction planning and downstream processing.
Waste reduction remains a top concern during both reaction steps and final purification, especially at scale. Instead of wrestling with hard-to-remove byproducts, chemists seek starting blocks that either simplify isolation or degrade benignly. In several green chemistry projects, 5-Bromo-2-(1H-tetrazol-5-yl)pyridine swapped into existing protocols without needing extra toxic reagents or longer purification columns. It’s always refreshing finding a reagent that doesn’t force extra expenditure just to comply with best practice.
The old guard in chemistry kept a stash of trusted reagents—their “go-to” bottle for troubleshooting or innovation. Cutting corners by using under-characterized material almost always led to regret. The lesson from repeated experience is to narrow your toolkit to a handful of reliable, transparent sources. Choosing compounds like 5-Bromo-2-(1H-tetrazol-5-yl)pyridine, with precisely reported batch data and trace impurity profiles, is less about perfection and more about predictability.
I’ve had the best outcomes working with vendors who share up-to-date data sheets, provide batch-specific analytical results, and remain responsive to traceability questions. On the lab floor, that meant fewer nights lost to mystery compounds and more time devoted to the actual science—testing hypotheses, scaling up successful reactions, and publishing honest, reproducible results. Process chemists benefit most by building workflows around trustworthy building blocks, streamlining their operations from bench to plant. Having an open line of communication with your supply chain partners identifies problems early, making late-stage issues less likely.
Today’s synthetic chemist juggles demands for creativity, cost control, and compliance. The molecular scaffolds selected early shape every decision downstream. A compound like 5-Bromo-2-(1H-tetrazol-5-yl)pyridine, well-supported by real data and proven in countless syntheses, grants more than just hassle-free cross-coupling. It offers control. In my hands and those of trusted colleagues, it provides the adaptability needed for evolving project targets in both pharma and materials science.
Looking through my own notebooks, I see a common thread: projects that started with sound, reliable building blocks stayed on track, met or beat deadlines, and yielded publishable outcomes. In contrast, those that cut corners at the building block stage bogged down in troubleshooting, repeating runs, or defending inconsistent results to skeptical reviewers.
A final consideration comes with advancing technology. As high-throughput screening and automated synthesis gain ground, reproducibility at scale—both in small vials and multi-kilo reactors—demands materials free of ambiguity. For teams committed to open science, transparent sourcing of key starting materials like this one stands as a cornerstone of modern research integrity. That trust in your starting point strengthens everything that follows, from the first reaction to the final product on the shelf.
The journey through research and development is rarely smooth, but starting with well-supported compounds eases the unavoidable bumps along the way. After seeing both the costs of neglect and the successes rooted in careful choice, my advice is simple: invest in proven, transparent precursors like 5-Bromo-2-(1H-tetrazol-5-yl)pyridine, and you’ll reap dividends in time, data quality, and overall project satisfaction.